ASCO GI 2022 Conference Coverage
Playback speed
10 seconds
ASCO GI 2022 Phase I/II Study of Regorafenib and Pembrolizumab in Refractory MSS CRC
By
ASCO GI 2022 Conference Coverage
FEATURING
Afsaneh Barzi
By
ASCO GI 2022 Conference Coverage
FEATURING
Afsaneh Barzi
233 views
February 1, 2022
Login to view comments.
Click here to Login
Videos